Prognostic Value of Circulating Biomarkers of Fibrotic Remodeling in Arrhythmogenic Cardiomyopathy.

Biomedicines

Department of Biomedical Sciences, Florida State University College of Medicine, Tallahassee, FL 32306, USA.

Published: November 2024

Arrhythmogenic cardiomyopathy (ACM) is a nonischemic, familial heart disease with a high risk of sudden cardiac death (SCD) in the pediatric population and accounts for >20% of SCDs worldwide [...].

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11592167PMC
http://dx.doi.org/10.3390/biomedicines12112623DOI Listing

Publication Analysis

Top Keywords

arrhythmogenic cardiomyopathy
8
prognostic circulating
4
circulating biomarkers
4
biomarkers fibrotic
4
fibrotic remodeling
4
remodeling arrhythmogenic
4
cardiomyopathy arrhythmogenic
4
cardiomyopathy acm
4
acm nonischemic
4
nonischemic familial
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!